Advertisement

Surgery Today

, 38:293 | Cite as

Liver resection for breast cancer metastasis: Does it improve survival?

  • Jean Lubrano
  • Horace Roman
  • Sophie Tarrab
  • Benoit Resch
  • Loïc Marpeau
  • Michel Scotté
Original Articles

Abstract

Purpose

To assess the outcome and prognostic factors of liver surgery for breast cancer metastasis.

Methods

We retrospectively examined 16 patients who underwent partial liver resection for breast cancer liver metastasis (BCLM). All patients had been treated with chemotherapy or hormonotherapy, or both, before referral for surgery. We confirmed by preoperative radiological examinations that metastasis was confined to the liver. The survival curve was estimated using the Kaplan-Meier method. Univariate and multivariate analysis were conducted to evaluate the role of the known factors of breast cancer survival.

Results

The median age of the patients was 54 years (range 38–68) and the median disease-free interval between the diagnoses of breast cancer and liver metastasis was 54 months (range 7–120). Nine major and 7 minor hepatectomies were performed. There was no postoperative death. The overall 1-, 3-, and 5-year survival rates were 94%, 61%, and 33%, respectively. The median survival rate was 42 months. Univariate analysis revealed that hormone receptor status, number of metastases, a major hepatectomy, and a younger age were associated with a poorer prognosis. The survival rate was not influenced by the disease-free interval, grade or stage of breast cancer, or intraoperative blood transfusions. The number of liver metastases was identified as a significant independent factor of survival according to the Cox proportional hazard model (P = 0.04).

Conclusions

Liver resection, when done in combination with adjuvant therapy, can improve the prognosis of selected patients with BCLM.

Key words

Liver resection Breast cancer Metastasis survival Adjuvant therapy 

References

  1. 1.
    Brun B, Benchalal M, Lebas C, Piedbois P, Lin M, Lebourgeois JP. Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment: prognostic factors. Cancer 1997;79(11):2137–2146.PubMedCrossRefGoogle Scholar
  2. 2.
    Elias D, Lasser P, Spielmann M, May-Levin F, el Malt O, Thomas H, et al. Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast. Surg Gynecol Obstet 1991;172(6):461–464.PubMedGoogle Scholar
  3. 3.
    Schneebaum S, Walker MJ, Young D, Farrar WB, Minton JP. The regional treatment of liver metastases from breast cancer. J Surg Oncol 1994;55(1):26–31; discussion 32.PubMedCrossRefGoogle Scholar
  4. 4.
    Maksan SM, Lehnert T, Bastert G, Herfarth C. Curative liver resection for metastatic breast cancer. Eur J Surg Oncol 2000;26(3):209–212.PubMedCrossRefGoogle Scholar
  5. 5.
    Pocard M, Pouillart P, Asselain B, Salmon R. Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol 2000;26(2):155–159.PubMedCrossRefGoogle Scholar
  6. 6.
    Elias D, Maisonnette F, Druet-Cabanac M, Ouellet JF, Guinebretiere JM, Spielmann M, et al. An attempt to clarify indications for hepatectomy for liver metastases from breast cancer. Am J Surg 2003;185(2):158–164.PubMedCrossRefGoogle Scholar
  7. 7.
    Sakamoto Y, Yamamoto J, Yoshimoto M, Kasumi F, Kosuge T, Kokudo N, et al. Hepatic resection for metastatic breast cancer: prognostic analysis of 34 patients. World J Surg 2005;29(4):524–527.PubMedCrossRefGoogle Scholar
  8. 8.
    Selzner M, Morse MA, Vredenburgh JJ, Meyers WC, Clavien PA. Liver metastases from breast cancer: long-term survival after curative resection. Surgery 2000;127(4):383–389.PubMedCrossRefGoogle Scholar
  9. 9.
    World Health Organization. World Health Organization handbook for reporting results of cancer treatment. Geneva: World Health Organization; 1979.Google Scholar
  10. 10.
    Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant JC, Balladur P, et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 1997;84(7):977–980.PubMedCrossRefGoogle Scholar
  11. 11.
    Nakamura S, Suzuki S, Baba S. Resection of liver metastases of colorectal carcinoma. World J Surg 1997;21(7):741–747.PubMedCrossRefGoogle Scholar
  12. 12.
    Harmon KE, Ryan JA Jr, Biehl TR, Lee FT. Benefits and safety of hepatic resection for colorectal metastases. Am J Surg 1999;177(5):402–404.PubMedCrossRefGoogle Scholar
  13. 13.
    Clark GM, Sledge GW Jr, Osborne CK, McGuire WL. Survival from first recurrence: relative importance of prognostic factors in 1015 breast cancer patients. J Clin Oncol 1987;5(1):55–61.PubMedGoogle Scholar
  14. 14.
    Insa A, Lluch A, Prosper F, Marugan I, Martinez-Agullo A, Garcia-Conde J. Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients. Breast Cancer Res Treat 1999;56(1):67–78.PubMedCrossRefGoogle Scholar
  15. 15.
    Koenders PG, Beex LV, Kloppenborg PW, Smals AG, Benraad TJ. Human breast cancer: survival from first metastasis. Breast Cancer Study Group. Breast Cancer Res Treat 1992;21(3):173–180.PubMedCrossRefGoogle Scholar
  16. 16.
    Pouillart P, Jouvet M, Palangie T, Garcia-Giralt E, Bretaudeau B, Dorval T, et al. Hepatic metastases of breast cancer. Analysis of the parameters which influence the response to chemotherapy. Ann Gastroenterol Hepatol (Paris) 1985;21(2):87–90.Google Scholar
  17. 17.
    Wyld L, Gutteridge E, Pinder SE, James JJ, Chan SY, Cheung KL, et al. Prognostic factors for patients with hepatic metastases from breast cancer. Br J Cancer 2003;89(2):284–290.PubMedCrossRefGoogle Scholar
  18. 18.
    O’Reilly SM, Richards MA, Rubens RD. Liver metastases from breast cancer: the relationship between clinical, biochemical and pathological features and survival. Eur J Cancer 1990;26(5):574–577.PubMedCrossRefGoogle Scholar
  19. 19.
    Rahman ZU, Frye DK, Smith TL, Asmar L, Theriault RL, Buzdar AU, et al. Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference. Cancer 1999;85(1):104–111.PubMedCrossRefGoogle Scholar
  20. 20.
    Lee YT. Breast carcinoma: pattern of recurrence and metastasis after mastectomy. Am J Clin Oncol 1984;7(5):443–449.PubMedCrossRefGoogle Scholar
  21. 21.
    Khalil HI, Patterson SA, Panicek DM. Hepatic lesions deemed too small to characterize at CT: prevalence and importance in women with breast cancer. Radiology 2005;235(3):872–878.PubMedCrossRefGoogle Scholar
  22. 22.
    Lind P, Igerc I, Beyer T, Reinprecht P, Hausegger K. Advantages and limitations of FDG PET in the follow-up of breast cancer. Eur J Nucl Med Mol Imaging 2004;31suppl 1:S125–S134.PubMedGoogle Scholar
  23. 23.
    Schirrmeister H, Kuhn T, Guhlmann A, Santjohanser C, Horster T, Nussle K, et al. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures. Eur J Nucl Med 2001;28:351–358.PubMedCrossRefGoogle Scholar
  24. 24.
    Yoshimoto M, Tada T, Saito M, Takahashi K, Uchida Y, Kasumi F. Surgical treatment of hepatic metastases from breast cancer. Breast Cancer Res Treat 2000;59(2):177–184.PubMedCrossRefGoogle Scholar
  25. 25.
    Vlastos G, Smith DL, Singletary SE, Mirza NQ, Tuttle TM, Popat RJ, et al. Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases. Ann Surg Oncol 2004;11(9):869–874.PubMedCrossRefGoogle Scholar
  26. 26.
    Lee CG, McCormick B, Mazumdar M, Vetto J, Borgen PI. Infiltrating breast carcinoma in patients age 30 years and younger: long term outcome for life, relapse, and second primary tumors. Int J Radiat Oncol Biol Phys 1992;23(5):969–975.PubMedGoogle Scholar
  27. 27.
    De Brux J. Histopathologie du sein. Paris: Masson; 1979.Google Scholar
  28. 28.
    Porter GJ, Evans AJ, Pinder SE, James JJ, Cornford EC, Burrell HC, et al. Patterns of metastatic breast carcinoma: influence of tumour histological grade. Clin Radiol 2004;59(12):1094–1098.PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Jean Lubrano
    • 1
  • Horace Roman
    • 2
  • Sophie Tarrab
    • 2
  • Benoit Resch
    • 2
  • Loïc Marpeau
    • 2
  • Michel Scotté
    • 1
    • 3
  1. 1.Department of Digestive SurgeryRouen University HospitalRouenFrance
  2. 2.Department of Gynecology and ObstetricsRouen University HospitalRouenFrance
  3. 3.Department of INSERM U 519Rouen University HospitalRouenFrance

Personalised recommendations